ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,500.91
-0.60%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Cue Biopharma Inc (CUE) 시세

Cue Biopharma Inc

Cue Biopharma Inc (CUE)

Cue Energy Resources Limited
1.31
0.03
(2.34%)
마감 18 1월 6:00AM
15분 지연
1.32
0.01
(0.76%)
시간외 거래: 9:59AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.31
매수가
1.20
매도가
1.36
거래량
201,615
1.22 일간 변동폭 1.32
0.45 52주 범위 3.03
market_cap
82.989M
전일 종가
1.28
개장가
1.30
최근 거래 시간
1
@
1.31
마지막 거래 시간
재정 규모
US$ 254,315
VWAP
1.2614
평균 볼륨(3m)
500,309
발행 주식
63,350,327
배당수익률
-
주가수익률
-1.65
주당순이익(EPS)
-0.8
매출
5.49M
순이익
-50.73M

Cue Biopharma Inc 정보

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.cuebiopharma.com
본부
Wilmington, Delaware, USA
설립됨
-
Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CUE. The last closing price for Cue Biopharma was US$1.28. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 3.03.

Cue Biopharma currently has 63,350,327 shares in issue. The market capitalisation of Cue Biopharma is US$81.09 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.65.

CUE 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

04 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 1월 2025
Edgar (US Regulatory)

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively...

30 11월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

30 11월 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

30 11월 2024
Edgar (US Regulatory)

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

25 11월 2024
GlobeNewswire Inc.

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

15 11월 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

15 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

15 11월 2024
Edgar (US Regulatory)

Cue Biopharma Announces Strategic Organizational Transition

Daniel Baker, M.D., will join Cue Biopharma’s executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific...

14 11월 2024
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.11-7.746478873241.421.531.22870241.29919198CS
40.294529.00049236831.01551.750.954165381.3137903CS
12-0.23-14.93506493511.541.98910.925003091.36826921CS
260.377940.54286020810.93211.98910.455755641.15171211CS
52-1.55-54.19580419582.863.030.454484061.35656107CS
156-8.56-86.72745694029.8711.230.453620682.85129034CS
260-15.67-92.28504122516.9835.50.453401057.56708929CS

CUE - Frequently Asked Questions (FAQ)

What is the current Cue Biopharma share price?
The current share price of Cue Biopharma is US$ 1.31
How many Cue Biopharma shares are in issue?
Cue Biopharma has 63,350,327 shares in issue
What is the market cap of Cue Biopharma?
The market capitalisation of Cue Biopharma is USD 81.09M
What is the 1 year trading range for Cue Biopharma share price?
Cue Biopharma has traded in the range of US$ 0.45 to US$ 3.03 during the past year
What is the PE ratio of Cue Biopharma?
The price to earnings ratio of Cue Biopharma is -1.65
What is the cash to sales ratio of Cue Biopharma?
The cash to sales ratio of Cue Biopharma is 15.22
What is the reporting currency for Cue Biopharma?
Cue Biopharma reports financial results in USD
What is the latest annual turnover for Cue Biopharma?
The latest annual turnover of Cue Biopharma is USD 5.49M
What is the latest annual profit for Cue Biopharma?
The latest annual profit of Cue Biopharma is USD -50.73M
What is the registered address of Cue Biopharma?
The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cue Biopharma website address?
The website address for Cue Biopharma is www.cuebiopharma.com
Which industry sector does Cue Biopharma operate in?
Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

CUE Discussion

게시물 보기
boston127 boston127 1 주 전
Send URL for the funds loading info.

I also bought today and last week, but am RED because I bought at a higher price.
👍️0
Hawkeye_tt Hawkeye_tt 1 주 전
You can easily see when a Fund is loading for the day.
I backed up the truck in the 50 cent dip area. That was a gift.
GL all.....be patient.

Hawk
👍️0
boston127 boston127 2 주 전
Today's volume was heavier than usual,

trading 1,209,308 shares, versus an average of 459,032 shares per day during the last twelve months. The On Balance Volume indicator (OBV) shows that longer term selling pressure has given way to near term accumulation by traders.
👍️0
boston127 boston127 2 주 전
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Good day today. Got back in recently. Will continue adding all the way to $3.
👍️0
boston127 boston127 2 주 전
Thanks. Interesting perspective.

As long as the company is doing well, I can wait and suffer through any dips.
👍️0
Hawkeye_tt Hawkeye_tt 2 주 전
This could be Over $5 right now...IMO. Algos/shorts walked this down for mths.
LT looks very good IMO.

Hawk
👍️0
boston127 boston127 2 주 전
Great day on Friday.

Wondering if profit taking will follow suit this week.
👍️0
Hawkeye_tt Hawkeye_tt 2 주 전
2025 should be a very good yr. New Partnerships and more.

Hawk
👍️0
glenn1919 glenn1919 2 주 전
cue.........................https://stockcharts.com/h-sc/ui?s=cue&p=W&b=5&g=0&id=p86431144783
👍️0
Hawkeye_tt Hawkeye_tt 3 월 전
TY for that quick dip/Algo dump op. Took advantage big time.
GL all...

Hawk
👍️0
boston127 boston127 3 월 전
Momentum for CUE is waning,

as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
👍️0
boston127 boston127 3 월 전
The On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
👍️0
boston127 boston127 3 월 전
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
👍️0
boston127 boston127 3 월 전
I got in on Friday. Everything

about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
👍️0
Monksdream Monksdream 3 월 전
CUE under $2
👍️0
Hawkeye_tt Hawkeye_tt 3 월 전
Look at that Wkly candle ! Vol fantastic.
LT outlook back on !

Hawk
👍️0
Triple nickle Triple nickle 3 월 전
CUE ready to win 1.02
👍️0
Hawkeye_tt Hawkeye_tt 4 월 전
Strong recovery on news....future looking good here. Buy, hold LT...
Hawk
👍️0
Monksdream Monksdream 7 월 전
CUE new 52 week low
👍️0
Hawkeye_tt Hawkeye_tt 2 년 전
CUE....this story grows quickly. Merck early investor.
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.

Hawk
👍️0
conix conix 3 년 전
CUE Insider Buy
Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
👍️0

최근 히스토리

NASDAQ
CUE
Cue Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유